ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 41 filers reported holding ATARA BIOTHERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,465 | -8.1% | 9,773,616 | 0.0% | 0.28% | -1.1% |
Q2 2023 | $15,736 | -40.5% | 9,773,616 | +7.1% | 0.28% | -38.1% |
Q1 2023 | $26,458 | -0.7% | 9,123,616 | +12.3% | 0.45% | +3.9% |
Q4 2022 | $26,645 | -99.9% | 8,123,616 | 0.0% | 0.44% | -17.9% |
Q3 2022 | $30,707,000 | -51.5% | 8,123,616 | 0.0% | 0.53% | -43.3% |
Q2 2022 | $63,283,000 | -16.1% | 8,123,616 | 0.0% | 0.94% | +15.3% |
Q1 2022 | $75,468,000 | -43.5% | 8,123,616 | -4.2% | 0.81% | -38.5% |
Q4 2021 | $133,605,000 | -12.0% | 8,477,488 | 0.0% | 1.32% | -5.4% |
Q3 2021 | $151,747,000 | +15.1% | 8,477,488 | 0.0% | 1.39% | +30.3% |
Q2 2021 | $131,825,000 | +8.3% | 8,477,488 | 0.0% | 1.07% | +10.4% |
Q1 2021 | $121,737,000 | -31.9% | 8,477,488 | -6.9% | 0.97% | -41.3% |
Q4 2020 | $178,809,000 | +39.1% | 9,108,988 | -8.2% | 1.65% | +18.7% |
Q3 2020 | $128,590,000 | -11.0% | 9,922,030 | 0.0% | 1.39% | -23.0% |
Q2 2020 | $144,564,000 | +104.4% | 9,922,030 | +19.4% | 1.80% | +72.9% |
Q1 2020 | $70,709,000 | -48.3% | 8,308,900 | 0.0% | 1.04% | -30.9% |
Q4 2019 | $136,848,000 | +16.6% | 8,308,900 | 0.0% | 1.51% | +13.7% |
Q3 2019 | $117,322,000 | -16.7% | 8,308,900 | +18.7% | 1.33% | +4.3% |
Q2 2019 | $140,770,000 | -44.5% | 7,000,000 | +9.7% | 1.27% | -40.2% |
Q1 2019 | $253,626,000 | +16.7% | 6,380,519 | +2.0% | 2.13% | +13.0% |
Q4 2018 | $217,286,000 | -16.0% | 6,254,632 | 0.0% | 1.89% | -4.8% |
Q3 2018 | $258,629,000 | +12.5% | 6,254,632 | 0.0% | 1.98% | -1.4% |
Q2 2018 | $229,858,000 | -5.8% | 6,254,632 | 0.0% | 2.01% | -14.5% |
Q1 2018 | $243,931,000 | +151.5% | 6,254,632 | +16.7% | 2.35% | +145.3% |
Q4 2017 | $97,009,000 | +9.4% | 5,359,632 | 0.0% | 0.96% | -13.3% |
Q3 2017 | $88,702,000 | +18.2% | 5,359,632 | 0.0% | 1.11% | +29.1% |
Q2 2017 | $75,035,000 | -31.9% | 5,359,632 | 0.0% | 0.86% | -33.9% |
Q1 2017 | $110,140,000 | +44.7% | 5,359,632 | 0.0% | 1.30% | +30.7% |
Q4 2016 | $76,107,000 | -33.6% | 5,359,632 | 0.0% | 0.99% | -39.1% |
Q3 2016 | $114,643,000 | -5.0% | 5,359,632 | 0.0% | 1.63% | -0.5% |
Q2 2016 | $120,645,000 | +18.3% | 5,359,632 | 0.0% | 1.64% | +11.2% |
Q1 2016 | $101,994,000 | -27.9% | 5,359,632 | 0.0% | 1.47% | -42.6% |
Q4 2015 | $141,548,000 | -16.0% | 5,359,632 | 0.0% | 2.57% | -8.6% |
Q3 2015 | $168,507,000 | -33.6% | 5,359,632 | +11.4% | 2.81% | -33.6% |
Q2 2015 | $253,756,000 | +31.6% | 4,809,632 | +1.0% | 4.23% | +30.6% |
Q1 2015 | $192,802,000 | +226.0% | 4,763,265 | +90.8% | 3.24% | +178.8% |
Q4 2014 | $59,137,000 | – | 2,495,913 | – | 1.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
Arctis Global LLC | 397,046 | $587,628 | 0.32% |
Baupost Group | 9,773,616 | $14,465 | 0.28% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |